| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/15/2001 | WO2001017535A2 Enriched fraction from a porcine liver extract for treating human diseases |
| 03/15/2001 | WO2001017524A1 Methods for treating cell proliferative disorders including cancer |
| 03/15/2001 | WO2001017522A1 Method of treating cancer using tetraethyl thiuram disulfide |
| 03/15/2001 | WO2001017517A2 Use of g(a)-linolenic acid metabolites in the manufacture of a medicament for the treatment or prevention of cancer |
| 03/15/2001 | WO2001017515A1 Degradable polymers |
| 03/15/2001 | WO2001017508A1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 03/15/2001 | WO2001017472A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | WO2000061609A3 Prodrugs of thrombin inhibitors |
| 03/15/2001 | WO2000057854A3 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances |
| 03/15/2001 | WO2000051613A8 Upper hitch link |
| 03/15/2001 | WO2000047733A9 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase |
| 03/15/2001 | WO2000044407A8 Materials and methods to inhibit hodgkin and reed sternberg cell growth |
| 03/15/2001 | WO2000044398A3 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions |
| 03/15/2001 | WO1999059996A8 Antitumour 1,5-diazaanthraquinones |
| 03/15/2001 | WO1999053076A9 Tao protein kinases and methods of use therefor |
| 03/15/2001 | DE19943839A1 Contactinhibin enthaltendes Arzneimittel sowie Arzneimittel, das gegen Contactinhibin gerichtete Antikörper enthält Contactinhibin medicated and drug containing antibodies directed against contactinhibin |
| 03/15/2001 | DE19943815A1 Verwendung von Thienopyrimidinen Use of Thienopyrimidinen |
| 03/15/2001 | DE19943708A1 Neue C13-substituierte Estra-1,3,5(10)-trien-3-yl-sulfamate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New C13-substituted estra-1,3,5 (10) -triene-3-yl-sulfamate, to their preparation and to pharmaceutical compositions containing these compounds, method |
| 03/15/2001 | DE19943508A1 3-Vinylpyrol-Derivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel 3 Vinylpyrol derivatives, processes for their preparation and their use as medicaments |
| 03/15/2001 | DE19942812A1 Verfahren zur Herstellung von D-(3'-Pyridyl)-alanin Process for the preparation of D- (3'-pyridyl) -alanine |
| 03/15/2001 | DE19941897A1 New deletion mutants of Interleukin-6 receptor protein useful for production of cell proliferation inhibitors for treatment of tumors, especially multiple myeloma |
| 03/15/2001 | DE19925668A1 Spleißosomprotein und seine Verwendung Spleißosomprotein and its use |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2388562A1 Mammalian cytokines; related reagents and methods |
| 03/15/2001 | CA2384679A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | CA2384671A1 Vitronectin receptor antagonists |
| 03/15/2001 | CA2384663A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | CA2384650A1 Apoptosis proteins |
| 03/15/2001 | CA2384634A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | CA2384456A1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 03/15/2001 | CA2384151A1 Inhibitors of prenyl-protein transferase |
| 03/15/2001 | CA2384101A1 Tyrosine kinase inhibitors |
| 03/15/2001 | CA2384099A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2383999A1 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 03/15/2001 | CA2383981A1 Integrin-mediated drug targeting |
| 03/15/2001 | CA2383798A1 Pulmonary delivery for bioconjugation |
| 03/15/2001 | CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | CA2383788A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2382729A1 29 human cancer associated proteins |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2382130A1 Novel chalcones |
| 03/15/2001 | CA2382112A1 Chalcone coumarins |
| 03/15/2001 | CA2349434A1 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 03/15/2001 | CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/14/2001 | EP1083224A2 Apoptin-associating protein |
| 03/14/2001 | EP1083177A1 Compounds capable of cleaving double-stranded dna and method of utilization of the same |
| 03/14/2001 | EP1083170A1 Method for producing D-(3'-Pyridyl)-alanine |
| 03/14/2001 | EP1082962A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZO C ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-$g(k)B |
| 03/14/2001 | EP1082456A1 Antisense modulation of cd40 expression |
| 03/14/2001 | EP1082433A1 Interleukins-21 and 22 |
| 03/14/2001 | EP1082429A2 TUMOUR SUPPRESSOR GENES OF THE p53 FAMILY |
| 03/14/2001 | EP1082426A2 Human socs proteins |
| 03/14/2001 | EP1082424A1 Tumor suppressor |
| 03/14/2001 | EP1082422A2 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation |
| 03/14/2001 | EP1082419A2 Combination therapy using nucleic acids and conventional drugs |
| 03/14/2001 | EP1082418A2 Combination therapy using nucleic acids and radio therapy |
| 03/14/2001 | EP1082415A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src |
| 03/14/2001 | EP1082411A2 Method for preparation and in vivo administration of antigen presenting cell composition |
| 03/14/2001 | EP1082344A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 03/14/2001 | EP1082341A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| 03/14/2001 | EP1082338A1 17 beta-nitro-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 03/14/2001 | EP1082337A1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 03/14/2001 | EP1082334A1 Alg-2lp, alg-2 like molecules and uses therefor |
| 03/14/2001 | EP1082331A1 Platinum complex conjugated to cyclotriphosphazene, its preparation, and anticancer agent comprising the same |
| 03/14/2001 | EP1082330A1 Platinum complex, its preparation and therapeutic application |
| 03/14/2001 | EP1082329A1 Platinum complex, its preparation and therapeutic application |
| 03/14/2001 | EP1082311A1 Quinazolines for treating brain tumor |
| 03/14/2001 | EP1082305A1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/14/2001 | EP1082302A1 A vla-4 inhibitor: omepupa-v |
| 03/14/2001 | EP1082298A2 1$g(a)-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF |
| 03/14/2001 | EP1082141A1 Cd40 binding molecules and ctl peptides for treating tumors |
| 03/14/2001 | EP1082138A1 Texaphyrin conjugates and uses thereof |
| 03/14/2001 | EP1082134A2 Composition comprising tumor cells and extracts and method of using thereof |
| 03/14/2001 | EP1082103A1 Spill resistant pharmaceutical compositions |
| 03/14/2001 | EP1082028A1 Matthiola seed oil, mixtures containing it and use thereof |
| 03/14/2001 | EP0804601B1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
| 03/14/2001 | EP0773782B1 Terpenoidic derivatives (sarcodictyins) useful as antitumor agents |
| 03/14/2001 | CN1287555A N-oxides of heterocyclic compounds with TNF and PDE IV inhibiting activity |
| 03/14/2001 | CN1287490A Pharmaceutical composition having antitumor activity and process for the preparation thereof |
| 03/14/2001 | CN1287485A Dysuria remedies |
| 03/14/2001 | CN1287127A Folica acid-polysaccharide composite and its preparation and medical composition with the composite as active component |
| 03/14/2001 | CN1287123A Steroid and its preparation method, medicine composition and application |
| 03/14/2001 | CN1287117A Cycloene derivate, its producing process and its therapeutical use |
| 03/14/2001 | CN1287008A Achyranthis bidentatae glycopeptide and its preparation |
| 03/14/2001 | CN1287003A Medicine for treating carcer of esophagus and its preparation |
| 03/14/2001 | CN1286993A Medicine for treating digestive tract diseases |
| 03/14/2001 | CN1286992A Medicine for resisting tumor and carcinomatosis |
| 03/14/2001 | CN1286985A Externally applied Chinese medicine |
| 03/14/2001 | CN1286983A Muscle and joint relaxing capsule |
| 03/14/2001 | CN1286923A Health tea and its production process |
| 03/14/2001 | CN1063182C Aminophenylphosphonic acid compounds, process for preparing them and medical composition containing them |
| 03/14/2001 | CN1063176C Chromone derivative |
| 03/14/2001 | CN1063076C Traditional herbal medicines preparation for raising leucocytes |
| 03/14/2001 | CN1063074C Chinese herbal medicine injection for treating tumor and its preparing method |
| 03/14/2001 | CN1063056C Oral liquid for relieving cancer pain of patient |
| 03/14/2001 | CN1063047C Capsule using clam extract as main medicinal component and producing mehtod thereof |
| 03/13/2001 | US6201154 Z-styryl sulfone anticancer agents |